HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease.

Abstract
The evidence that degeneration in the basal forebrain cholinergic nuclei in Alzheimer's disease is a secondary phenomenon is reviewed. Experimental retrograde degeneration in these nuclei shares some common features with the degeneration actually observed in the disease, and can occur without direct damage to the cholinergic axons within the cortex. The neuroanatomical distribution of the pathological changes typical of Alzheimer's disease in the neocortex suggests a progression of the disease process, from the medial temporal cortex and amygdala out into the parieto-temporal association areas. Neurochemical evidence also points to the early and severe involvement of the amygdala in the disease. The close reciprocal relationship between the amygdala and the basal nucleus may underly the degeneration seen in the basal nucleus in Alzheimer's disease.
AuthorsR C Pearson, T P Powell
JournalJournal of neural transmission. Supplementum (J Neural Transm Suppl) Vol. 24 Pg. 139-46 ( 1987) ISSN: 0303-6995 [Print] Austria
PMID3119773 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Topics
  • Alzheimer Disease (pathology)
  • Amygdala (pathology)
  • Animals
  • Basal Ganglia (pathology)
  • Cerebral Cortex (pathology)
  • Haplorhini
  • Humans
  • Nerve Degeneration
  • Rats
  • Retrograde Degeneration
  • Substantia Innominata (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: